Bio-Rad introduces CFX Opus Dx real-time PCR detection systems for IVD use

By | October 25, 2021
Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, today announced the launch of the CFX™ Opus 96 Dx System and the CFX™ Opus 384 Dx System, real-time PCR detection systems that have been listed with the U.S. Food and Drug Administration for IVD testing and that meet the CE-IVD requirement for IVD use in Europe.